Keros Therapeutics, Inc. (KROS)
NASDAQ: KROS · Real-Time Price · USD
17.48
-0.02 (-0.11%)
At close: Nov 28, 2025, 1:00 PM EST
17.52
+0.04 (0.23%)
After-hours: Nov 28, 2025, 4:17 PM EST
Keros Therapeutics Market Cap
Keros Therapeutics has a market cap or net worth of $532.55 million as of November 28, 2025. Its market cap has decreased by -80.71% in one year.
Market Cap
532.55M
Enterprise Value
-143.50M
1-Year Change
-80.71%
Ranking
Category
Stock Price
$17.48
Market Cap Chart
Since April 8, 2020, Keros Therapeutics's market cap has increased from $385.32M to $532.55M, an increase of 38.21%. That is a compound annual growth rate of 5.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 26, 2025 | 533.16M | -16.85% |
| Dec 31, 2024 | 641.23M | -46.17% |
| Dec 29, 2023 | 1.19B | -9.94% |
| Dec 30, 2022 | 1.32B | -3.39% |
| Dec 31, 2021 | 1.37B | -16.27% |
| Dec 31, 2020 | 1.64B | 324.32% |
| Apr 8, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 961.84B |
| Johnson & Johnson | 495.35B |
| AbbVie | 401.50B |
| UnitedHealth Group | 300.15B |
| AstraZeneca | 287.99B |
| Merck & Co. | 259.64B |
| Novartis AG | 249.49B |
| Abbott Laboratories | 224.85B |